Progress and prospects of biomarkers of bronchopulmonary dysplasia in premature infants
10.3760/cma.j.issn.1673-4912.2019.12.011
- VernacularTitle: 早产儿支气管肺发育不良生物标记物的研究进展
- Author:
Yuqing PAN
1
;
Jianhua FU
Author Information
1. Neonatal Department, Shengjing Hospital of China Medical University, Shenyang 110004, China
- Publication Type:Review
- Keywords:
Biomarker;
Bronchopulmonary dysplasia;
Premature
- From:
Chinese Pediatric Emergency Medicine
2019;26(12):932-936
- CountryChina
- Language:Chinese
-
Abstract:
Bronchopulmonary dysplasia(BPD)is one of the most serious lung diseases in premature infants and an important cause of death in preterm infants.The pathophysiological mechanism of BPD is still unclear.The preventive and targeted treatment strategies for this disease are also very limited.However, various biomarkers have been found in blood, alveolar lavage fluid, exhaled gas condensate, and urine.It is used to identify high-risk children with BPD early and to predict the severity and prognosis of the disease.
